1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. MMP

MMP (基质金属蛋白酶)

Matrix metalloproteinases

MMP(基质金属蛋白酶)是锌依赖性内肽酶。MMP 属于一个更大的蛋白酶家族,称为 metzincin 超家族。MMP 能够降解所有类型的细胞外基质蛋白,但也能处理许多生物活性分子。已知它们参与细胞表面受体的裂解、凋亡配体的释放和趋化因子/细胞因子失活。MMP 还被认为在细胞行为(如细胞增殖、迁移、分化、血管生成、凋亡和宿主防御)中发挥重要作用。MMP-2 和 MMP-9 被认为在转移中很重要。MMP-1 被认为在类风湿性关节炎和骨关节炎中很重要。最近的数据表明 MMP 在主动脉瘤的发病机制中发挥着积极作用。过量的 MMP 会降解主动脉壁的结构蛋白。MMPs和TIMPs之间平衡的失调也是急性和慢性心血管疾病的特征。

MMPs (Matrix metalloproteinases) are zinc-dependent endopeptidases. The MMPs belong to a larger family of proteases known as the metzincin superfamily. MMPs are capable of degrading all kinds of extracellular matrix proteins, but also can process a number of bioactive molecules. They are known to be involved in the cleavage of cell surface receptors, the release of apoptotic ligands and chemokine/cytokine inactivation. MMPs are also thought to play a major role on cell behaviors such as cell proliferation, migration, differentiation, angiogenesis, apoptosis, and host defense. MMP-2 and MMP-9 are thought to be important in metastasis. MMP-1 is thought to be important in rheumatoid arthritis and osteoarthritis. Recent data suggests active role of MMPs in the pathogenesis of Aortic Aneurysm. Excess MMPs degrade the structural proteins of the aortic wall. Disregulation of the balance between MMPs and TIMPs is also a characteristic of acute and chronic cardiovascular diseases.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0565
    Doxycycline

    多西环素

    Inhibitor 98.40%
    Doxycycline 是一种具有口服活性的四环素抗生素,是广谱的金属蛋白酶 (MMP) 抑制剂,具有抗菌活性和抗癌细胞增殖活性。
    Doxycycline
  • HY-N0565B
    Doxycycline hyclate

    多西环素盐酸盐半乙醇半水合物

    Inhibitor 99.19%
    Doxycycline hyclate 是一种具有口服活性的四环素抗生素,是广谱的金属蛋白酶 (MMP) 抑制剂,具有抗菌活性和抗癌细胞增殖活性。
    Doxycycline hyclate
  • HY-12270
    T-5224 Inhibitor 99.59%
    T-5224 是选择性的转录因子 c-Fos/activator protein (AP)-1 抑制剂,具有抗炎活性,能特异性抑制 c-Fos/c-Jun 的 DNA 结合活性,而不影响其他转录因子的结合活性。T-5224 抑制 IL-1β 诱导的 Mmp-3、Mmp-13、Adamts-5 转录上调。
    T-5224
  • HY-B0239
    Chloramphenicol

    氯霉素

    Inducer 99.93%
    Chloramphenicol 是一种口服有效的广谱抗生素 (antibiotic)。Chloramphenicol 具有抗菌 (antibacterial) 活性。Chloramphenicol 抑制缺氧 A549 和 H1299 细胞中氧不稳定转录因子和缺氧诱导因子-1α (HIF-1α)。Chloramphenicol 可抑制血管内皮生长因子 (VEGF) 和葡萄糖转运蛋白 1 (glucose transporter 1) 的 mRNA 水平,最终降低 VEGF 的释放。Chloramphenicol 可用于厌氧菌感染和肺癌研究。
    Chloramphenicol
  • HY-15768
    Ilomastat

    伊洛马司他

    Inhibitor 98.39%
    Ilomastat (GM6001) 是一种有效、广谱的基质金属蛋白酶 (MMP) 抑制剂,能够抑制 MMP 的活性, IC50 值分别为 1.5 nM (MMP-1),1.1 nM (MMP-2),1.9 nM (MMP-3),0.5 nM (MMP-9),对人皮肤成纤维细胞胶原酶 (MMP-1) 的 Ki 值为 0.4 nM。
    Ilomastat
  • HY-W001925
    7-Methoxy-1-tetralone Inhibitor 99.93%
    7-Methoxy-1-tetralone 是一种强效的抗肿瘤试剂。7-Methoxy-1-tetralone 抑制癌细胞增殖和迁徙,并诱导肝细胞癌细胞 (HCC) 凋亡 (apoptosis)。7-Methoxy-1-tetralone 能够降低 NF-κB、基质金属肽酶 2 (MMP2)/MMP9 和 p-AKT 的蛋白水平。7-Methoxy-1-tetralone 在裸鼠体内具有抗肿瘤活性,对体重和肝脾脏器指数没有影响。
    7-Methoxy-1-tetralone
  • HY-N0565AR
    Doxycycline (hydrochloride) (Standard)

    盐酸多西环素 (Standard)

    Inhibitor
    Doxycycline (hydrochloride) (Standard)是 Doxycycline (hydrochloride) 的分析标准品。本产品用于研究及分析应用。Doxycycline hydrochloride 是一种具有口服活性的四环素抗生素,是广谱的金属蛋白酶 (MMP) 抑制剂,具有抗菌活性和抗癌细胞增殖活性。
    Doxycycline (hydrochloride) (Standard)
  • HY-P2166A
    MMP3 inhibitor 3 TFA Inhibitor
    MMP3 inhibitor 3 (TFA) 是 MMP3 的抑制剂。MMP3 inhibitor 3 (TFA) 可用于乳腺癌的研究。
    MMP3 inhibitor 3 TFA
  • HY-E70005D
    Collagenase IV, Clostridium histolytica

    胶原酶IV

    Collagenase, Type IV (EC 3.4.24.3) 是一种来源于微生物的基质金属蛋白酶 (MMP) 和锌肽酶。Collagenase, Type IV 降解基底膜的主要成分 IV、VII 型胶原蛋白,还可以分解基底基质和弹性蛋白。

    Collagenase IV, Clostridium histolytica
  • HY-N0431
    Astragaloside IV

    黄芪皂苷 IV

    Inhibitor 99.93%
    Astragaloside IV 是从黄芪中分到的皂苷类物质,能够抑制 ERK1/2JNK 的激活,在乳腺癌细胞 MDA-MB-231 中,能够下调 (MMP)-2,(MMP)-9 的信号通路。
    Astragaloside IV
  • HY-B0099
    Edaravone

    依达拉奉

    Inhibitor 99.89%
    Edaravone 是一种新颖的,有效的自由基清除剂,能够抑制大鼠与 MMP-9 有关的脑出血。
    Edaravone
  • HY-E70005B
    Collagenase, Type II

    胶原酶II

    Collagenase, Type II 是一种来源于微生物的基质金属蛋白酶 (MMP) 和锌肽酶。Collagenase, Type II 分解胶原蛋白1、3、5、7、8、10、纤连蛋白、明胶、聚集蛋白聚糖。

    Collagenase, Type II
  • HY-E70005A
    Collagenase, Type I

    胶原酶I

    Collagenase, Type I 是一种来源于微生物的基质金属蛋白酶 (MMP) 和锌肽酶。Collagenase, Type I 分解胶原蛋白 1、3、7、8、10、明胶、蛋白聚糖、聚集蛋白聚糖。

    Collagenase, Type I
  • HY-N2117
    Isoginkgetin

    异银杏素

    Inhibitor 99.95%
    Isoginkgetin 是一种 pre-mRNA splicing 抑制剂。Isoginkgetin 也抑制 AktNF-κBMMP-9 的活性。Isoginkgetin 抑制 20S proteasome,诱导细胞凋亡(apoptosis),激活自噬(autophagy)。
    Isoginkgetin
  • HY-N0262
    Cordycepin

    虫草素

    Inhibitor 99.43%
    Cordycepin (3'-Deoxyadenosine) 是一种核苷衍生物,在类风湿性关节炎滑膜成纤维细胞 (RASF) 中,抑制 IL-1β 诱导的 MMP-1MMP-3 表达,这种作用存在剂量依赖性。Cordycepin 通过抑制细菌的腺苷激酶杀死结核分枝杆菌。
    Cordycepin
  • HY-N0565A
    Doxycycline hydrochloride

    盐酸多西环素

    Inhibitor 99.99%
    Doxycycline hydrochloride 是一种具有口服活性的四环素抗生素,是广谱的金属蛋白酶 (MMP) 抑制剂,具有抗菌活性和抗癌细胞增殖活性。
    Doxycycline hydrochloride
  • HY-12169
    Marimastat

    马立马司他

    Inhibitor 99.81%
    Marimastat (BB2516) 是一种广谱的,具有口服活性的 MMPs 抑制剂,有效抑制 MMP-9 (IC50=3 nM), MMP-1 (IC50=5 nM), MMP-2 (IC50=6 nM), MMP-14 (IC50=9 nM), MMP-7 (IC50=13 nM),用于癌症的研究。Marimastat (BB2516) 是一种血管生成和转移抑制剂,限制血管的生长和生成。作为一种抗变形剂,Marimastat (BB2516) 可以防止恶性细胞突破基底膜。
    Marimastat
  • HY-N0318
    Salvianolic acid A

    丹酚酸 A

    99.72%
    Salvianolic acid A 可通过抑制基质金属钛酶 9 (MMP-9) 和抗炎作用来保护血脑屏障。
    Salvianolic acid A
  • HY-N0131
    Stigmasterol

    豆甾醇

    Inhibitor ≥98.0%
    Stigmasterol (Stigmasterin) 是一种植物性甾醇,不仅具有降低胆固醇的活性,并且在风湿性疾病的研究中被评价为抗硬化因子。
    Stigmasterol
  • HY-19956
    GI254023X Inhibitor 99.67%
    GI254023X 是一种有效的 MMP9ADAM10 抑制剂, IC50s 分别为 2.5 和 5.3 nM。
    GI254023X
目录号 产品名 / 同用名 种属 表达系统
目录号 产品名 / 同用名 应用 反应物种

MMP-1

MMP-2

MMP-3

MMP-8

MMP-9

MMP-13

MMP-14

MMP-17

ADAM10

ADAM17

MMP-7

MMP-12

MMP-10

MMP

ADAM8

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

MMP (基质金属蛋白酶) Inducers, Inhibitors, Agonists, Activators & Chemicals
Product NameMMP-1MMP-2MMP-3MMP-8MMP-9MMP-13MMP-14MMP-17ADAM10ADAM17MMP-7MMP-12MMP-10MMPADAM8Purity    
Chloramphenicol     
MMP13
         99.93%
Ilomastat
Fibroblast collagenase, Ki: 0.4 nM (Human skin)
MMP-1, IC50: 1.5 nM
MMP-2, IC50: 1.1 nM
MMP-3, IC50: 1.9 nM
 
MMP-9, IC50: 0.5 nM
          98.39%
MMP3 inhibitor 3 TFA  
MMP3
            
Astragaloside IV 
MMP-2
  
MMP-9
          99.93%
Cordycepin
MMP-1
 
MMP-3
            99.43%
Marimastat
MMP-1, IC50: 5 nM
MMP-2, IC50: 6 nM
MMP-3, IC50: 3 nM
   
MMP-14, IC50: 9 nM
   
MMP-7, IC50: 13 nM
    99.81%
Salvianolic acid A    
MMP-9
          99.72%
GW280264X        
ADAM10, IC50: 11.5 nM
ADAM17, IC50: 8 nM
     98.28%
Meloxicam 
MMP-2
             99.70%
SB-3CT 
MMP-2, Ki: 13.9 nM
  
MMP-9, Ki: 600 nM
          99.59%
MMP-9-IN-1    
MMP-9
          99.71%
Tranexamic acid
MMP-1
              ≥98.0%
TAPI-2             
MMP, IC50: 20 μM
 
Aderbasib        
ADAM10
ADAM17
     99.44%
KP-457 
MMP2, IC50: 717 nM
MMP3, IC50: 9760 nM
MMP8, IC50: 2200 nM
MMP9, IC50: 5410 nM
MMP13, IC50: 930 nM
MMP14, IC50: 2140 nM
MMP17, IC50: 7100 nM
ADAM10, IC50: 748 nM
ADAM17, IC50: 11.1 nM
     99.18%
Indinavir sulfate 
MMP-2
             99.97%
Lixisenatide
MMP-1
 
MMP-3
  
MMP13
         99.93%
FSL-1 TFA    
MMP-9
          99.65%
Luteolin 7-O-glucuronide
MMP-1, IC50: 17.63 μM
 
MMP-3, IC50: 7.99 μM
MMP-8, IC50: 11.42 μM
MMP-9, IC50: 12.85 μM
MMP13, IC50: 0.03 μM
         99.80%
ARP-100
MMP-1, IC50: >50 μM
MMP-2, IC50: 12 nM
MMP-3, IC50: 4.5 μM
 
MMP-9, IC50: 0.2 μM
     
MMP-7, IC50: >50 μM
    ≥99.0%
Cetrimonium bromide 
MMP-2
  
MMP-9
          ≥98.0%
Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2
MMP-1, Km: 27.5 μM
    
MMP-13, Km: 5.2 μM
MMP-14, Km: 7.9 μM
        99.87%
TMI-1
MMP-1, IC50: 6.6 nM
MMP-2, IC50: 4.7 nM
  
MMP-9, IC50: 12 nM
 
MMP-14, IC50: 26 nM
   
MMP-7, IC50: 26 nM
    99.59%
8-Gingerol    
MMP-9
          99.82%
Morroniside 
MMP2
  
MMP9
          99.88%
Auraptene 
MMP-2
             99.96%
Cynaropicrin     
MMP13
         99.79%
Hepcidin-1 (mouse) (TFA)    
MMP-9
          98.94%
Isofraxidin          
MMP-7
    99.00%
Prinomastat
MMP-1, IC50: 79 nM
MMP-2, Ki: 0.05 nM
MMP-3, IC50: 6..3 nM
MMP-3, Ki: 0.3 nM
 
MMP-9, IC50: 5 nM
MMP-9, Ki: 0.26 nM
collagenases 3, Ki: 0.03 nM
         99.27%
Apigenin-7-glucuronide  
MMP-3, IC50: 12.87 μM
MMP-8, IC50: 22.39 μM
MMP-9, IC50: 17.52 μM
MMP13, IC50: 0.27 μM
         99.73%
UK 356618
MMP-1, IC50: 51 μM
MMP-2, IC50: 1.79 μM
MMP-3, IC50: 5.9 nM
 
MMP-9, IC50: 0.84 μM
MMP-13, IC50: 73 nM
MMP-14, IC50: 1.9 μM
        98.91%
MMP-7-IN-1          
MMP-7, IC50: 10 nM
    99.68%
Ginkgolide C    
MMP-9
          ≥98.0%
JG26   
MMP-8, IC50: 240 nM
MMP-9, IC50: >500000 nM
MMP-9, IC50: 1630 nM
 
MMP14, IC50: 19500 nM
 
ADAM10, IC50: 150 nM
ADAM17, IC50: 1.9 nM
 
MMP-12, IC50: 9.4 nM
  
ADAM8, IC50: 12 nM
98.01%
PD-166793
MMP-1, IC50: 6.0 μM
MMP-2, IC50: 4 nM
MMP-3, IC50: 7 nM
 
MMP-9, IC50: 7.9 μM
MMP-13, IC50: 8 nM
    
MMP-7, IC50: 7.2 μM
    99.45%
β-Neo-Endorphin 
MMP-2
  
MMP-9
          99.32%
Isoliquiritin apioside    
MMP9
          99.87%
PPNDS tetrasodium        
ADAM10, IC50: 1.2 μM
      
Anethole    
MMP-9
          99.78%
SM-7368    
MMP-9
          99.77%
MMP-2 Inhibitor I 
MMP-2, Ki: 1.7 μM
             99.23%
PF-00356231 hydrochloride  
MMP-3, IC50: 0.39 μM
MMP-8, IC50: 1.7 μM
MMP-9, IC50: 0.98 μM
MMP13, IC50: 0.65 nM
     
MMP-12, IC50: 1.4 μM
   99.52%
MMP-8 inhibitor-1   
MMP-8
           ≥98.0%
YH-306 
MMP2
  
MMP9
          98.34%
MMP3 inhibitor 1
MMP-1, IC50: 14000 nM
MMP-2, IC50: 529 nM
MMP-3, IC50: 1 nM
 
MMP-9, IC50: 2420 nM
 
MMP-14, IC50: 20100 nM
        99.03%
ND-336 
MMP-2, Ki: 85 nM
  
MMP-9, Ki: 150 nM
 
MMP-14, Ki: 120 nM
        
S 3304    
MMP-9
          99.11%
MMP-1-IN-1
MMP-1, IC50: 0.034 μM
              99.10%
NFF-3 TFA  
MMP-3
         
MMP-10
  98.54%
UK-370106 
MMP-2, IC50: 34.2 μM
MMP-3, IC50: 23 nM
MMP-8, IC50: 1.75 μM
MMP-9, IC50: 30.4 μM
MMP-13, IC50: 2.3 μM
MMP-14, IC50: 66.9 μM
   
MMP-7, IC50: 5.8 μM
MMP-12, IC50: 42 nM
   ≥99.0%
Mca-PLAQAV-Dpa-RSSSR-NH2 TFA        
ADAM10
ADAM17
     99.21%
MMP-7-IN-2 
MMP-2, IC50: 33000
MMP-3, IC50: >100000
MMP-8, IC50: >100000
MMP-9, IC50: >100000
MMP-13, IC50: >100000
MMP-14, IC50: 11000 nM
   
MMP-7, IC50: 16 nM
MMP-12, IC50: 12000 nM
   99.59%
Tanomastat 
MMP-2, Ki: 11 nM
MMP-3, Ki: 143 nM
 
MMP-9, Ki: 301 nM
MMP-13, Ki: 1470 nM
         99.7%
Cipemastat
collagenases 1, Ki: 3.0 nM
gelatinase A, Ki: 154 nM
stromelysins 1, Ki: 527 nM
collagenases 2, Ki: 4.4 nM
gelatinase B, Ki: 59.1 nM
collagenases 3, Ki: 3.4 nM
         99.81%
BI-4394 
MMP-2, IC50: 18 μM
  
MMP-9, IC50: 8.9 μM
MMP-13, IC50: 1 nM
MMP-14, IC50: 8.3 μM
     
MMP-10, IC50: 16 μM
  99.09%
MMP2-IN-1 
MMP2, IC50: 6.8 μM
             99.18%
XL-784
MMP-1, IC50: 1900 nM
MMP-2, IC50: 0.81 nM
MMP-3, IC50: 120 nM
MMP-8, IC50: 10.8 nM
MMP-9, IC50: 18 nM
MMP13, IC50: 0.56 nM
         98.25%
Prinomastat hydrochloride
MMP-1, IC50: 79 nM
MMP-2, Ki: 0.05 nM
MMP-13, IC50: 6.3 nM
MMP-13, Ki: 0.3 nM
 
MMP-9, IC50: 5 nM
MMP-9, Ki: 0.26 nM
collagenases 3, Ki: 0.03 nM
         98.18%
MMP Inhibitor II
MMP-1, IC50: 24 nM
 
MMP-3, IC50: 18.4 nM
 
MMP-9, IC50: 2.7 nM
     
MMP-7, IC50: 30 nM
    ≥99.0%
MMP13-IN-2 
MMP-2, IC50: 180 nM
MMP-3, IC50: 1100 nM
  
MMP-13, IC50: 0.036 nM
         99.85%
PI3K/AKT-IN-2 
MMP-2
             98.10%
Otaplimastat             
MMP
 98.41%
TP0597850 
MMP2, IC50: 0.22 nM
   
MMP13, IC50: 240 nM
     
MMP-12, IC50: 250 nM
   99.09%
MMP-9/10-IN-2            
MMP-10, IC50: 0.076 μM
  99.91%
MMPI-1154
MMP-1, IC50: 10 μM
MMP-2, IC50: 6.6 μM
  
MMP-9, IC50: 13 μM
MMP-13, IC50: 1.8 μM
         99.87%
β-Anhydroicaritin  
MMP-3
            99.69%
MMP-9/MMP-13 Inhibitor I
MMP-1, IC50: 43 nM
 
MMP-3, IC50: 23 nM
 
MMP-9, IC50: 0.9 nM
MMP-13, IC50: 0.9 nM
    
MMP-7, IC50: 931 nM
    99.90%
Imidapril hydrochloride    
MMP-9
          99.80%
DB04760     
MMP-13, IC50: 8 nM
         99.33%
MMP2-IN-3 
MMP-2, IC50: 31 ± 5 μM
 
MMP-8, IC50: 32 ± 4 μM
MMP-9, IC50: 26.6 ± 2.3 μM
MMP-13, IC50: >100 μM
         99.64%
Hydrangenol
MMP-1
 
MMP-3
            99.63%
MMP2-IN-2 
MMP-2, IC50: 4.2 ± 0.2 μM
 
MMP-8, IC50: 25 ± 10 μM
MMP-9, IC50: 23.3 ± 10. μM
MMP13, IC50: 12 ± 7 μM
         98.80%
RXP470.1           
human MMP-12, Ki: 0.2 nM
   
Imidapril    
MMP-9
          ≥99.0%
Indinavir 
MMP-2
             99.96%
Hepcidin-1 (mouse)    
MMP-9
          
CTTHWGFTLC, CYCLIC TFA 
MMP-2
  
MMP-9
          98.91%
CMC2.24
MMP-1, IC50: 69.8 μM
MMP-2, IC50: 4.8 μM
MMP-3, IC50: 2.9 μM
MMP-8, IC50: 4.5 μM
MMP-9, IC50: 8 μM
MMP-13, IC50: 2.7 μM
MMP-14, IC50: 15.3 μM
   
MMP-7, IC50: 5 μM
MMP-12, IC50: 2 μM
   
Mca-Pro-Leu-Ala-Cys(Mob)-Trp-Ala-Arg-Dap(Dnp)-NH2      
MMP-14
        
CP-471474
MMP-1, IC50: 1170 nM
MMP-2, IC50: 0.7 nM
MMP-3, IC50: 16 nM
 
MMP-9, IC50: 13 nM
MMP-13, IC50: 0.9 nM
         99.2%
BPHA
MMP-1, IC50: 974 nM
MMP-2, IC50: 12 nM
MMP-3, IC50: >1000 nM
 
MMP-9, IC50: 16 nM
 
MMP-14, IC50: 17 nM
   
MMP-7, IC50: 795 nM
    
cis-ACCP 
MMP-2, IC50: 4 μM
  
MMP-9, IC50: 20 μM
          
MMP-9-IN-9
MMP-1, IC50: 1050 nM
   
MMP-9, IC50: 5 nM
MMP-13, IC50: 113 nM
         
Flocoumafen    
MMP-9
          99.17%
MMP-9-IN-5
MMP-1, IC50: 104 nM
MMP-2, IC50: 266 nM
  
MMP-9, IC50: 4.49 nM
MMP-13, IC50: 280 nM
         
Nudol 
MMP-2, Ki: 988.9 nM
  
MMP-9, Ki: 1.76 μM
          
CL-82198 hydrochloride     
MMP13
         
FFAGLDD TFA    
MMP9
          
CTTHWGFTLC, CYCLIC 
MMP-2
  
MMP-9
          
SD-7300 
MMP-2, Ki: 0.03 nM
  
MMP-9, Ki: 0.01 nM
MMP13, Ki: 0.03 nM
         
MMP-9-IN-7    
MMP-9, IC50: 0.52 μM
          
Indinavir sulfate ethanolate 
MMP-2
             
MMP-13-IN-1     
MMP13, IC50: 16 nM
         
NFF-3  
MMP-3
         
MMP-10
  
Mca-PLAQAV-Dpa-RSSSR-NH2        
ADAM10
ADAM17
     
(R)-ND-336 
MMP-2, Ki: 127 nM
  
MMP-9, Ki: 19 nM
 
MMP-14, Ki: 119 nM
        
Dnp-PLGLWA-DArg-NH2 TFA
MMP-1
   
MMP-9
          
Meloxicam sodium 
MMP-2
             
ROCK2-IN-7 
MMP-2
             
MMP-2 Inhibitor-4 
MMP-2, IC50: 152.62 nM
             
MMP-9-IN-4
MMP-1, IC50: 41 nM
MMP-2, IC50: 139 nM
  
MMP-9, IC50: 7.46 nM
MMP-13, IC50: 113 nM
         
FFAGLDD    
MMP9
          
XL-784 free base
MMP-1, IC50: 1900 nM
MMP-2, IC50: 0.81 nM
MMP-3, IC50: 120 nM
MMP-8, IC50: 10.8 nM
MMP-9, IC50: 18 nM
MMP-13, IC50: 0.56 nM
         
MMP12-IN-3           
MMP-12, IC50: 4.9 nM
   
Ageladine A dihydrochloride
MMP-1, IC50: 2.79 μM
MMP-2, IC50: 4.65 μM
 
MMP-8, IC50: 907.12 nM
MMP-9, IC50: 1.83 μM
MMP13, IC50: 1.09 μM
     
MMP-12, IC50: 767.57 nM
   
(Rac)-Tanomastat 
MMP-2, Ki: 11 nM
MMP-3, Ki: 143 nM
 
MMP-9, Ki: 301 nM
MMP-13, Ki: 1470 nM
         
MMP-9-IN-3
MMP-1, IC50: 447 nM
MMP-2, IC50: 221 nM
  
MMP-9, IC50: 5.56 nM
MMP13, IC50: 295 nM
         
CP-544439
MMP-1, IC50: 420 nM
MMP-2, IC50: 1.6 nM
MMP-3, IC50: 16 nM
MMP-8, IC50: 1.4 nM
MMP-9, IC50: 12 nM
MMP-13, IC50: 0.75 nM
MMP-14, IC50: 7.4 nM
    
MMP-12, IC50: 0.24 nM
   
HNHA 
MMP-2
  
MMP-9
          99.76%
Anticancer agent 65             
MMP
 
DH-18 
MMP-2, IC50: 139.45 nM
 
MMP-8, IC50: 833.34 nM
MMP-9, IC50: 518.11 nM
          
Anticancer agent 183    
MMP-9
          
Halociline    
MMP-9
          
AChE-IN-51 
MMP-2, IC50: 724 nM
             
Mca-P-Cha-G-Nva-HA-Dap(DNP)-NH2
MMP-1
 
MMP-3
            
MMP-2/9-IN-1 
MMP-2, IC50: 56 nM
  
MMP-9, IC50: 38 nM
          
TP0556351 
MMP-2, IC50: 0.2 nM
             
Funalenone
collagenases 1
              
MMP-2 Inhibitor II
MMP-1, Ki: 45 μM
MMP-2, Ki: 2.4 μM
        
MMP-7, Ki: 379 μM
    
WAY-170523
MMP-1, IC50: 10 μM
   
MMP-9, IC50: 945 nM
MMP13, IC50: 17 nM
         
proMMP-9 selective inhibitor-1    
MMP-9
          
Stevia Powder 
MMP-2
   
MMP13
         
ABT-770
MMP-1, IC50: 4600 nM
MMP-2, IC50: 4 nM
             
CIL-102 
MMP-2
  
MMP-9
          
LY52 
MMP-2
  
MMP-9
          
CM-352  
MMP-3, IC50: 15 nM
         
MMP-10, IC50: 12 nM
  
WAY-151693     
MMP13
         
3-Aminobenzene-1,2-diol 
MMP-2, IC50: 20 μM
 
MMP-8, IC50: 26 μM
MMP-9, IC50: 16 μM
 
MMP-14, IC50: 16.3 μM
        
CGS 27023A
collagenases 1, Ki: 33 nM
MMP-2, Ki: 20 nM
stromelysins 1, Ki: 43 nM
 
MMP-9, Ki: 8 nM
          
RS-104966
collagenases 1
              
BR351 
MMP-2, IC50: 4 nM
 
MMP-8, IC50: 2 nM
MMP-9, IC50: 11 nM
MMP13, IC50: 50 nM
         
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》